Published • loading... • Updated
Spherix Global Insights Finds One-Third of Treated MASH Patients Remain Inadequately Controlled ...
Summary by Enid News & Eagle
2 Articles
2 Articles
Hastings TribuneReposted by 
Enid News & Eagle
Enid News & EagleSpherix Global Insights Finds One-Third of Treated MASH Patients Remain Inadequately Controlled ...
Exton, PA, Aug. 20, 2026 (GLOBE NEWSWIRE) -- The treatment landscape for metabolic dysfunction-associated steatohepatitis (MASH) is expanding as prescription therapy becomes integrated into routine patient management. Despite this progress, substantial unmet needs persist, with many treated patients experiencing suboptimal…
·Nebraska, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
